Interstitial Lung Disease Treatment Market Emerging Trends, Global Demand and Top Key Players 2024
Global Interstitial Lung Disease Treatment Market was valued at USD 1.1 Billion in 2023 and is expected to reach USD 1.70 Billion by the year 2032, at a CAGR of 4.97%.
Interstitial lung disease (ILD) encompasses a diverse range of respiratory disorders characterized by inflammation and progressive scarring (fibrosis) of lung tissue. This scarring leads to stiffness in the lungs, impairing their ability to exchange gases effectively and resulting in inadequate oxygen supply to the bloodstream. Symptoms of ILD typically include